Valuation: InterCure Ltd.

Market Cap 19Cr 0 16Cr 15Cr 14Cr 26Cr 1.79TCr 26Cr 179.33Cr 69Cr 905.11Cr 71Cr 69Cr 3TCr P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 32Cr 0 28Cr 26Cr 24Cr 45Cr 3.09TCr 45Cr 309.31Cr 119.87Cr 1.56TCr 121.82Cr 119.17Cr 5.17TCr EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
60.83%
Yield 2024 *
-
Yield 2025 -
1 day+2.85%
1 week+33.26%
Current month+12.32%
1 month+21.50%
3 months+29.60%
6 months+40.06%
Current year+9.33%
1 week 1,261.5
Extreme 1261.5
1,862
1 month 1,255
Extreme 1255
1,862
Current year 1,126.5
Extreme 1126.5
1,862
1 year 1,126.5
Extreme 1126.5
2,834.5
3 years 1,126.5
Extreme 1126.5
6,730
5 years 1,126.5
Extreme 1126.5
13,175
10 years 734.13
Extreme 734.1278
31,589.75
Manager TitleAgeSince
Chief Executive Officer 55 24/12/2019
Director of Finance/CFO 47 01/03/2020
General Counsel - 01/04/2022
Director TitleAgeSince
Director/Board Member 50 03/09/2015
Director/Board Member 66 14/12/2014
Chairman 55 13/02/2025
Date Insider Type Main position Quantity % Market Cap.
18/03/26 Other

Director

15,000 0.0274%
09/11/22 Option

Chief Financial Officer

2,30,000 0.5066%
09/11/22 Option 2,30,000 0.5066%
Change 5-day change 1-year change 3-year change Capi.($)
+2.85%+33.26%-36.13%-37.91% 6.31Cr
+1.91%+12.84%-0.51%+288.52% 35Cr
-1.69%+1.75%-23.68%-9.84% 18Cr
0.00%+2.04%+9.29%+90.48% 14Cr
-2.22%+2.33%-39.73%-8.33% 9.14Cr
-1.72%+1.79%+5.56%+35.71% 5.19Cr
0.00%+100.00%+100.00%-60.00% 5.04Cr
Average -0.12%+22.27%+2.11%+42.66% 13.31Cr
Weighted average by Cap. +0.27%+14.40%-3.97%+116.37%

Financials

2024 2025
Net sales 24Cr 0 21Cr 19Cr 18Cr 33Cr 2.28TCr 33Cr 227.71Cr 88Cr 1.15TCr 90Cr 88Cr 3.81TCr 27Cr 0 23Cr 22Cr 20Cr 38Cr 2.58TCr 38Cr 257.6Cr 100Cr 1.3TCr 101.45Cr 99Cr 4.31TCr
Net income -6.78Cr -0 -5.82Cr -5.46Cr -4.99Cr -9.41Cr -646.62Cr -9.46Cr -65Cr -25Cr -326.21Cr -25Cr -25Cr -1.08TCr -3.57Cr -0 -3.06Cr -2.88Cr -2.63Cr -4.96Cr -340.6Cr -4.98Cr -34Cr -13Cr -171.83Cr -13Cr -13Cr -569.11Cr
Net Debt 13Cr 0 11Cr 11Cr 9.77Cr 18Cr 1.27TCr 19Cr 126.56Cr 49Cr 638.77Cr 50Cr 49Cr 2.12TCr 14Cr 0 12Cr 11Cr 10Cr 19Cr 1.3TCr 19Cr 129.98Cr 50Cr 656.02Cr 51Cr 50Cr 2.17TCr
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
26/26/26 ILA 1,769.00 +2.85% 56,087
25/26/25 ILA 1,720.00 +9.00% 1,42,752
24/26/24 ILA 1,578.00 +20.37% 2,46,635
21/26/21 ILA 1,311.00 +1.67% 11,379
20/26/20 ILA 1,289.50 -2.86% 22,313
  1. Stock Market
  2. Stocks
  3. INCR Stock